Diluted Drug Case Settlement Two drug companies that sold chemotherapy medications to a pharmacist who illegally diluted them reach a settlement with his customers. Eli Lilly and Bristol-Myers Squibb agree to pay $71 million to 360 plaintiffs, who claim sales records should have exposed the drug tampering scheme years before the FBI uncovered it. Frank Morris of member station KCUR reports.

Pharmaceutical Firms Reach Settlement in Diluted Drug Case

Pharmaceutical Firms Reach Settlement in Diluted Drug Case

  • Download
  • <iframe src="https://www.npr.org/player/embed/995354/995355" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Two drug companies that sold chemotherapy medications to a pharmacist who illegally diluted them reach a settlement with his customers. Eli Lilly and Bristol-Myers Squibb agree to pay $71 million to 360 plaintiffs, who claim sales records should have exposed the drug tampering scheme years before the FBI uncovered it. Frank Morris of member station KCUR reports.